SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-234062
Filing Date
2021-08-03
Accepted
2021-08-03 08:03:32
Documents
17
Period of Report
2021-08-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d191890d8k.htm   iXBRL 8-K 50097
2 EX-2.1 d191890dex21.htm EX-2.1 462399
3 EX-99.1 d191890dex991.htm EX-99.1 51140
4 EX-99.2 d191890dex992.htm EX-99.2 56241
5 EX-99.3 d191890dex993.htm EX-99.3 25708
9 GRAPHIC g191890dsp1.jpg GRAPHIC 8560
  Complete submission text file 0001193125-21-234062.txt   938174

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA tbio-20210802.xsd EX-101.SCH 2881
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE tbio-20210802_lab.xml EX-101.LAB 17372
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tbio-20210802_pre.xml EX-101.PRE 10945
10 EXTRACTED XBRL INSTANCE DOCUMENT d191890d8k_htm.xml XML 3230
Mailing Address 29 HARTWELL AVENUE LEXINGTON MA 02421
Business Address 29 HARTWELL AVENUE LEXINGTON MA 02421 617-945-7361
Translate Bio, Inc. (Filer) CIK: 0001693415 (see all company filings)

IRS No.: 611807780 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38550 | Film No.: 211138046
SIC: 2836 Biological Products, (No Diagnostic Substances)